Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Analogs of Thalidomide as Potential Angiogenesis Inhibitors

  • Read more about Analogs of Thalidomide as Potential Angiogenesis Inhibitors
European Patent
02780964.9
Filed on 2002-02-26

INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3' - DIDEOXYINOSINE

  • Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3' - DIDEOXYINOSINE
Mexico
9203377
Filed on 1992-06-25

Identification of New Small RNAs and ORFs of E. Coli as Mediators of Cell and Intercell Regulation

  • Read more about Identification of New Small RNAs and ORFs of E. Coli as Mediators of Cell and Intercell Regulation
US Patent 7,119,193
Filed on 2003-07-25

Gene Expression Is Silenced In Chromosomal Amplicons In Colorectal Carcinomas (CRC)

  • Read more about Gene Expression Is Silenced In Chromosomal Amplicons In Colorectal Carcinomas (CRC)
US Application 10/318,578
Filed on 2002-12-12

NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES

  • Read more about NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES
Switzerland
97937243.0
Filed on 1997-08-14

NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES

  • Read more about NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES
France
97937243.0
Filed on 1997-08-14

NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES

  • Read more about NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES
Germany
97937243.0
Filed on 1997-08-14

NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES

  • Read more about NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES
United Kingdom
97937243.0
Filed on 1997-08-14

Chromosome 3p21.3 Genes Are Tumor Suppressors

  • Read more about Chromosome 3p21.3 Genes Are Tumor Suppressors
Australia
2001273337
Filed on 2001-07-10

Glycosylation-Resistant Cyanovirins And Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods Of Production...

  • Read more about Glycosylation-Resistant Cyanovirins And Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods Of Production...
Japan
576632/2002
Filed on 2003-09-19

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1115
  • Page 1116
  • Page 1117
  • Page 1118
  • Page 1119
  • Page 1120
  • Page 1121
  • Page 1122
  • Page 1123
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health